India's Pharmaceutical Exports

Country Profile

Netherlands Antilles

Netherlands Antilles is a developing market for Indian pharmaceuticals — $2.57M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $22K. The compound annual growth rate since FY2016 stands at 5.8%.

🇦🇳 $2.57M · 1.8× growth since FY2016 · 5.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.57M
Exports FY2025–26 DGCIS
1.8×
Growth FY2016→2026
5.8%
CAGR FY2016→2026
95%
Medicines Share
3
Product Categories Supplied
Netherlands Antilles is a developing market for Indian pharmaceuticals — $2.57M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $22K. The compound annual growth rate since FY2016 stands at 5.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.43M (94.5%) Traditional & Herbal $119K (4.6%) Vaccines $22K (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Netherlands Antilles in the RBI overseas direct investment dataset (2011–2026).